Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Gastroenteritis
1.3.3 GI Bleeding
1.3.4 Irritable Bowel Syndrome
1.3.5 Peptic Ulcer Disease (PUD)
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2018-2034)
2.2 Gastrointestinal Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2024-2034)
2.3 Gastrointestinal Therapeutics and Diagnostics Market Dynamics
2.3.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
2.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
2.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
2.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
3.4 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2024
3.5 Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2034)
5 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2034)
6.2 North America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2034)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2034)
8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2034)
9.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2034)
10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
11.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Eisai
11.3.1 Eisai Company Detail
11.3.2 Eisai Business Overview
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
11.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.3.5 Eisai Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
11.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Detail
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
11.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Detail
11.6.2 Takeda Pharmaceutical Company Business Overview
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
11.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
11.6.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2018-2023)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2024-2034)
Table 10. Gastrointestinal Therapeutics and Diagnostics Market Trends
Table 11. Gastrointestinal Therapeutics and Diagnostics Market Drivers
Table 12. Gastrointestinal Therapeutics and Diagnostics Market Challenges
Table 13. Gastrointestinal Therapeutics and Diagnostics Market Restraints
Table 14. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players (2018-2023)
Table 16. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2024)
Table 17. Ranking of Global Top Gastrointestinal Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
Table 21. Date of Enter into Gastrointestinal Therapeutics and Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2018-2023)
Table 25. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2024-2034)
Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2018-2023)
Table 29. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2024-2034)
Table 31. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product
Table 49. Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product
Table 54. AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Eisai Company Detail
Table 57. Eisai Business Overview
Table 58. Eisai Gastrointestinal Therapeutics and Diagnostics Product
Table 59. Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 60. Eisai Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product
Table 64. Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Salix Pharmaceuticals Company Detail
Table 67. Salix Pharmaceuticals Business Overview
Table 68. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product
Table 69. Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Salix Pharmaceuticals Recent Development
Table 71. Takeda Pharmaceutical Company Company Detail
Table 72. Takeda Pharmaceutical Company Business Overview
Table 73. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product
Table 74. Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Takeda Pharmaceutical Company Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2024 VS 2034
Figure 3. Diagnostics Features
Figure 4. Therapeutics Features
Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2024 VS 2034
Figure 7. Gastroenteritis Case Studies
Figure 8. GI Bleeding Case Studies
Figure 9. Irritable Bowel Syndrome Case Studies
Figure 10. Peptic Ulcer Disease (PUD) Case Studies
Figure 11. Others Case Studies
Figure 12. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2024 VS 2034
Figure 16. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2024
Figure 17. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2024
Figure 19. North America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2034)
Figure 21. United States Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2034)
Figure 25. Germany Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2018-2034)
Figure 33. China Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2034)
Figure 41. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2034)
Figure 45. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 49. Eisai Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 52. Takeda Pharmaceutical Company Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed